BOT · ASX

Botanix Pharmaceuticals Limited (ASX:BOT)

AU$0.36

 -0.025 (-6.41%)
ASX:Live
20/12/2024 04:10:10 PM
Recent Price downgrade HALO Small HALO Ords HALO Momentum GROWTH AUS +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BOT Overview

BOT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Very Strong

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Strong

About BOT

Website

Botanix Pharmaceuticals Limited

Telephone

61.8.62850083

Address

Suite 3 41–47 Colin Street West Perth, Western Australia (WA) 6005

Description

Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. It operates through the Australia and the United States geographical segments. The company was founded by Matthew Callahan, Roger New, and Glen Travers in 1984 and is headquartered in West Perth, Australia.

BOT Price Chart

Key Stats

Market Cap

AU$699.79M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.16 - 0.44

Trade Value (12mth)

AU$424,432.00

1 week

5.41%

1 month

23.81%

YTD

105.26%

1 year

136.36%

All time high

163.33

Key Fundamentals

EPS 3 yr Growth

170.60%

EBITDA Margin

%

Operating Cashflow

-$8m

Free Cash Flow Return

-12.30%

ROIC

-21.10%

Interest Coverage

-1,443.60

Quick Ratio

21.90

Other Data

Shares on Issue (Fully Dilluted)

1810m

HALO Sector

Healthcare

Next Company Report Date

28-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.03

BOT Announcements

Latest Announcements

Date Announcements

17 December 24

First Sofdra Prescriptions as Commercialisation Ramps Up

×

First Sofdra Prescriptions as Commercialisation Ramps Up

03 December 24

Change of Director's Interest Notice x 5

×

Change of Director's Interest Notice x 5

02 December 24

Application for quotation of securities - BOT

×

Application for quotation of securities - BOT

02 December 24

Notification regarding unquoted securities - BOT

×

Notification regarding unquoted securities - BOT

02 December 24

Section 708A(5)(e) Notice

×

Section 708A(5)(e) Notice

19 November 24

Botanix Presentation at Bell Potter Healthcare Conference

×

Botanix Presentation at Bell Potter Healthcare Conference

14 November 24

Botanix Adds to Payer Coverage

×

Botanix Adds to Payer Coverage

04 November 24

Annual General Meeting - Chairman's Address

×

Annual General Meeting - Chairman's Address

04 November 24

Annual General Meeting - Presentation

×

Annual General Meeting - Presentation

04 November 24

Results of Annual General Meeting

×

Results of Annual General Meeting

28 October 24

September 2024 Quarterly Activities Report and Appendix 4C

×

September 2024 Quarterly Activities Report and Appendix 4C

08 October 24

Application for quotation of securities - BOT

×

Application for quotation of securities - BOT

08 October 24

Notification of cessation of securities - BOT

×

Notification of cessation of securities - BOT

08 October 24

Section 708A(5)(e) Notice

×

Section 708A(5)(e) Notice

03 October 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

03 October 24

Letter to Shareholders - Notice of Annual General Meeting

×

Letter to Shareholders - Notice of Annual General Meeting

03 October 24

Botanix Staff Update and AGM Notice of Meeting

×

Botanix Staff Update and AGM Notice of Meeting

24 September 24

Botanix Investor Presentations and Roadshow

×

Botanix Investor Presentations and Roadshow

19 September 24

Annual Report

×

Annual Report

19 September 24

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

16 September 24

Botanix Webinar - Presentation Copy

×

Botanix Webinar - Presentation Copy

11 September 24

Botanix Commercial Day Webinar - Registration Information

×

Botanix Commercial Day Webinar - Registration Information

10 September 24

2024 Annual General Meeting - Key Dates

×

2024 Annual General Meeting - Key Dates

04 September 24

Notification of cessation of securities - BOT

×

Notification of cessation of securities - BOT

04 September 24

Application for quotation of securities - BOT

×

Application for quotation of securities - BOT

BOT Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -297.1 41.5 -16.5 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -375.1 56.1 9.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock -20.2 -8.1 -1.6 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.01 0.02 0.06 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.00 0.01 0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock -76.7 86.6 370.1 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 973 1,154 1,502 Lock Lock Lock
Basic m Lock Lock Lock Lock 973 1,154 1,502 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 13.1 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 16 10 8 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 -3 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -52.3 -2,022.6 -100.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -332.9 -591.4 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 0 433 691 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -16 -13 -15 Lock Lock Lock
     Growth % Lock Lock Lock Lock -55.3 19.7 -21.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -1,386.4 -1,487.3 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -16 -13 -15 Lock Lock Lock
     Growth % Lock Lock Lock Lock -55.3 19.7 -20.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -1,398.5 -1,494.3 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -16 -13 -15 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -3 -4 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -13 -9 -14 Lock Lock Lock
     Growth % Lock Lock Lock Lock -295.0 30.5 -51.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -1,000.5 -1,340.6 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -11 -12 -8 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 3 7 18 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -3 -7 -18 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 22 95 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -11 -12 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -276.0 -8.0 31.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -13.2 -8.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 7 10 79 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 14 25 112 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -7 -10 -79 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 6 2 4 Lock Lock Lock
Equity $m Lock Lock Lock Lock 8 23 109 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 8 23 109 Lock Lock Lock
     Growth % Lock Lock Lock Lock -61.0 181.5 373.8 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -93.8 -36.9 -12.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -161.6 -39.9 -12.8 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -108.7 -82.0 -23.5 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -90.6 -58.9 -21.1 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -77.0 -77.6 -12.3 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -421.9 -155.2 -1,443.6 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.5 0.8 5.2 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -87.9 -44.7 -72.9 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.8 7.4 22.2 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.3 5.7 21.9 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 69.4 73.3 95.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -190.0 -640.5 -217.8 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 2.9 0.7 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.1 1.3 3.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.1 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 0.0 152.0 263.7 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 0.0 -1,401.5 -1,482.5 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 0.0 -51.6 -13.6 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -93.8 -36.9 -12.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.7 1.1 1.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -161.6 -39.9 -12.8 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -161.6 -39.9 -12.8 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 3,871.8 285.3 111.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 0.0 125.6 489.3 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 3,871.8 410.9 600.5 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 305.4 272.7 144.1 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 3,566.4 138.2 456.3 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.03%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BOT Shortsell

Frequently Asked Questions

The current share price of Botanix Pharmaceuticals Limited (BOT:ASX) is AU$0.36.
The 52-week high share price for Botanix Pharmaceuticals Limited (BOT:ASX) is AU$0.44.
The 52-week low share price for Botanix Pharmaceuticals Limited (BOT:ASX)? is AU$0.16.
Botanix Pharmaceuticals Limited (BOT:ASX) does not pay a dividend.
Botanix Pharmaceuticals Limited (BOT:ASX) does not pay a dividend.
Botanix Pharmaceuticals Limited (BOT:ASX) has a franking level of 0.0%.
Botanix Pharmaceuticals Limited (BOT:ASX) is classified in the Healthcare.
The current P/E ratio for Botanix Pharmaceuticals Limited (BOT:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.